CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation Sudden Cardiac Arrest Survivorship: A Scientific Statement From the American Heart Association Routine Continuous Electrocardiographic Monitoring Following Percutaneous Coronary Interventions 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques Impact of Coronary Lesion Complexity in Percutaneous Coronary Intervention: One-Year Outcomes From the Large, Multicentre e-Ultimaster Registry Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study Rare Genetic Variants Associated With Sudden Cardiac Death in Adults Appropriate Use Criteria and Health Status Outcomes Following Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the OPEN-CTO Registry Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis

Guideline2016 Jan 14;37(3):267-315.

JOURNAL:Eur Heart J. Article Link

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)

Roffi M, Patrono C, ESC Scientific Document Group. Keywords: Acute cardiac care; Acute coronary syndromes; Angioplasty; Anticoagulation; Apixaban; Aspirin; Atherothrombosis; Beta-blockers; Bivalirudin; Bypass surgery; Cangrelor; Chest pain unit; Clopidogrel; Dabigatran; Diabetes; Early invasive strategy; Enoxaparin; European Society of Cardiology; Fondaparinux; Glycoprotein IIb/IIIa inhibitors; Guidelines; Heparin; High-sensitivity troponin; Myocardial ischaemia; Nitrates; Non-ST-elevation myocardial infarction; Platelet inhibition; Prasugrel; Recommendations; Revascularization; Rhythm monitoring; Rivaroxaban; Statin; Stent; Ticagrelor; Unstable angina; Vorapaxar

FULL TEXT PDF